[{"Assets_0_FY_USD":4023690000.0,"CommonStockSharesConverted_0_FY_shares":172647588.0,"CommonStockSharesOutstanding_0_FY_shares":172647588.0,"EarningsPerShareBasic_4_FY_USD":-3.8,"EarningsPerShareDiluted_4_FY_USD":-3.81,"NetIncomeLossConverted_4_FY_USD":-630210000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-227837000.0,"RevenuesConverted_4_FY_USD":1110381000.0,"StockholdersEquity_0_FY_USD":2766275000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":166219000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":165985000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170227"}]